How to recover from leukemia disease symptoms?(Jan 2024)
Leukemia is a type of cancer that affects the blood-forming tissues, including the bone marrow and the lymphatic system. It is a heterogeneous group of hematologic malignancies that arise from the dysfunctional proliferation of developing leukocytes. Leukemia is classified as either acute or chronic based on the rapidity of proliferation and as myelocytic.
The disease is caused by mutations in the DNA of a single cell in the bone marrow, which leads to the uncontrolled growth of abnormal blood cells that crowd out healthy blood cells in the bone marrow, leading to fewer healthy white blood cells, red blood cells, and platelets. Symptoms of leukemia include recurrent infections, weight loss, fatigue, fevers, abdominal pain, and bleeding.
Treatment depends on the type of leukemia but generally involves chemotherapy. The involvement of healthcare professionals from across specialties and disciplines is needed to achieve effective management, mitigate adverse events, and ensure the quality of life of patients.
Symptoms
The symptoms of leukemia vary depending on the type of leukemia and the stage of the disease. Some common symptoms include:
- Fatigue: Tiredness that lasts a long time and doesn't improve with rest.
- Bruising and bleeding more easily, or bleeding that takes longer to stop.
- Infections that are more frequent, severe, or last longer.
- Swollen lymph nodes (glands in the neck, armpit, and groin).
- Breathlessness.
- Loss of appetite.
- Headaches
Causes
The exact causes of leukemia are not fully understood, but several factors have been identified as potential contributors to the development of the disease. These factors include:
- Genetic Abnormalities: Certain genetic disorders, such as Down syndrome, are associated with an increased risk of leukemia.
- Chemical Exposure: Exposure to certain chemicals, such as benzene (found in gasoline and used by the chemical industry), is linked to an increased risk of leukemia.
- Radiation: High levels of radiation exposure can increase the chances of developing leukemia.
- Smoking: Cigarette smoking has been linked to an increased risk of acute myelogenous leukemia.
- Previous Cancer Treatment: Some cancer treatments, such as alkylating chemotherapy agents and radiation therapy, may increase the risk of developing leukemia.
Diagnosis
The diagnosis of leukemia involves a series of tests and procedures to confirm the presence of abnormal blood cells. The initial diagnosis of leukemia is usually made by analyzing a patient's blood sample through a complete blood count (CBC) or by using flow cytometry
. A bone marrow biopsy is often performed to confirm the diagnosis and determine the percentage of abnormal cells in the bone marrow.
The biopsy involves removing a small sample of bone marrow from the hipbone using a long, thin needle. The sample is then examined under a microscope to check for the presence of leukemia cells. Other specialized tests, such as genetic testing, may also be performed to determine the type of leukemia and its characteristics. It is essential to consult a healthcare professional if you experience any symptoms of leukemia, as early diagnosis and treatment can significantly improve the chances of successful treatment.
Recovering from leukemia
Recovering from leukemia symptoms involves a combination of medical treatment, lifestyle changes, and support from healthcare professionals and loved ones. Here are some steps to help you recover:
- Follow your treatment plan: Work closely with your healthcare team to ensure you are following the recommended treatment plan, which may include chemotherapy, targeted therapy, radiation therapy, stem cell transplant, or CAR T-cell therapy.
- Manage side effects: Be aware of the potential side effects of your treatment and discuss them with your healthcare team. They can provide guidance on how to manage these side effects and improve your quality of life.
- Stay active: Engage in gentle physical activity, such as walking, to help reduce fatigue and improve overall well-being.
- Eat a healthy diet: Maintain a balanced diet to support your recovery and overall health. Consult with a nutritionist or dietitian if needed.
- Get enough rest: Ensure you get adequate rest and sleep to help your body recover from treatment.
Survival rates for leukemia
The survival rates for leukemia vary depending on the specific subtype of the disease. The 5-year survival rate among people diagnosed with leukemia is 65%, but this statistic varies greatly according to the specific subtype of the disease. For instance, the 5-year survival rates for different subtypes are as follows:
The survival rate is higher for younger people, and for children with acute lymphocytic leukemia (ALL), the 5-year survival rate is around 90%. Overall, the survival rates for leukemia have been improving over the years, with more than 4 in 10 people diagnosed with leukemia today predicted to survive their disease for more than 10 years. It's important to note that these statistics are based on large groups of people and cannot predict the outcome for any individual patient.
- Chronic lymphocytic leukemia (CLL): 88%
- Acute lymphocytic leukemia (ALL): 71.3%
- Chronic myeloid leukemia (CML): 70.6%
- Acute myeloid leukemia (AML): 31.7%
- Acute monocytic leukemia (AML-M5): 23.7%
Treatment for leukemia
The treatment for leukemia varies depending on the type of leukemia, the patient's age, and overall health. Common treatments include:
- Chemotherapy: This is the major form of treatment for leukemia. It uses drugs to kill leukemia cells. The drugs may be given in the form of pills, or they may be injected directly into a vein.
- Targeted Therapy: This treatment focuses on specific abnormalities present within cancer cells. By blocking these abnormalities, targeted therapy can cause cancer cells to die.
- Radiation Therapy: This treatment uses X-rays or other high-energy beams to damage leukemia cells and stop their growth.
- Stem Cell Transplant: Also known as a bone marrow transplant, this procedure involves replacing the diseased bone marrow with healthy bone marrow from a donor.
- Chimeric Antigen Receptor (CAR) T-Cell Therapy: This is a novel type of therapy that takes the body's infection-fighting T-cells and engineers them to better fight cancer cells.
Here are some medicines used to treat leukemia:
| Type of Medicine | Examples |
|---|---|
| Chemotherapy | Arsenic Trioxide, Azacitidine, Cerubidine (Daunorubicin Hydrochloride), Cyclophosphamide, Cytarabine, Daunorubicin Hydrochloride, Daurismo (Glasdegib Maleate), Dexamethasone, Doxorubicin Hydrochloride, Enasidenib Mesylate, Gemtuzumab Ozogamicin, Gilteritinib Fumarate, Glasdegib Maleate, Methotrexate Sodium, Vincristine Sulfate |
| Targeted Therapy | Imatinib Mesylate, Dasatinib, Nilotinib, Bosutinib, Ponatinib, Blinatumomab, Inotuzumab Ozogamicin |
| Radiation Therapy | External Beam Radiation Therapy, Internal Radiation Therapy |
| Stem Cell Transplant | Allogeneic Stem Cell Transplant, Autologous Stem Cell Transplant |
| CAR T-Cell Therapy | Kymriah (Tisagenlecleucel), Yescarta (Axicabtagene Ciloleucel) |
Servival rate
The survival rate for leukemia varies depending on the type and age of the individual. Here are some key points regarding the survival rates for different types of leukemia:
- Acute Myeloid Leukemia (AML):5-Year Relative Survival Rate
- Acute Lymphocytic Leukemia (ALL):5-Year Relative Survival Rate
- Chronic Lymphocytic Leukemia (CLL):The relative 5-year survival rate for CLL in people of all ages is not specified in the provided sources.
- Chronic Myeloid Leukemia (CML):The five-year survival rate for all ages with CML is approximately not specified in the provided sources.
Risk factors
Leukemia is a complex disease with various risk factors that can influence its development. While the exact causes of leukemia remain largely unknown, scientists have identified several key risk factors associated with the disease:
- Age:
- The risk of developing leukemia increases with age, with most cases diagnosed in individuals over 65 years old. However, acute lymphocytic leukemia (ALL) is more common in people under 20 years old.
- Gender:
- Men are more likely than women to develop leukemia, although the reason for this gender difference is not entirely clear.
- Blood Disorders:
- Certain blood disorders like chronic myeloproliferative disorders such as polycythemia vera, idiopathic myelofibrosis, and essential thrombocythemia can increase the chances of developing acute myeloid leukemia (AML).
- Family History:
- While most leukemias have no direct familial link, individuals with a first-degree relative with chronic lymphocytic leukemia (CLL) or an identical twin with AML or ALL may have an increased risk of developing the disease.
- Congenital Syndromes:
- Certain congenital syndromes like Down syndrome, Fanconi anemia, Bloom syndrome, ataxia-telangiectasia, and Blackfan-Diamond syndrome are associated with a higher risk of AML.
- Smoking:
- Smoking cigarettes increases the risk of developing AML, although it may not be a direct cause of leukemia.
- Radiation Exposure:
- Exposure to high-energy radiation from sources like atomic bomb explosions or intense exposure to low-energy radiation from electromagnetic fields can elevate the risk of developing leukemia.
- Chemical Exposure:
- Long-term exposure to certain chemicals like benzene, found in pesticides and industrial settings, is considered a risk factor for leukemia.
- Previous Cancer Therapy:
- Certain types of chemotherapy and radiation therapy used to treat other cancers can increase the risk of developing leukemia later on.
Conclusion
The diagnosis and treatment of leukemia are complex due to the various subtypes of the disease. The production of abnormal leukocytes defines leukemia as either a primary or secondary process, and it can be classified as acute or chronic based on the rapidity of proliferation and myeloid or lymphocytic based on the cell type involved.
Treatment depends on the type of leukemia but generally involves chemotherapy. Multiple genetic and environmental risk factors are identified in the development of leukemia. It is essential to consider the unique characteristics of each case and to involve an interprofessional team to ensure the best possible care and management for patients with leukemia.


If u have any doubts, please let me know